Insulin Resistance and Polycystic Ovarian Syndrome

Evaluation for Insulin Resistance and Comorbidities Related to Insulin Resistance in Polycystic Ovary Syndrome.- Fat Distribution and Adipose Products in Polycystic Ovary Syndrome.- Treatment of Infertility in Polycystic Ovary Syndrome.- Imaging Studies in Polycystic Ovary Syndrome.- Genes Related to Metabolic Abnormalities or Insulin Resistance in Polycystic Ovary Syndrome.- Anti-Androgens.- Lipid Abnormalities in Polycystic Ovary Syndrome.- Serine Phosphorylation, Insulin Resistance, and the Regulation of Androgen Synthesis.- Chronic Treatment of Polycystic Ovary Syndrome.- Insulin-Sensitizing Drugs for the Treatment of Infertility in Polycystic Ovary Syndrome.- Diet and Lifestyle Factors in the Etiology and Management of Polycystic Ovary Syndrome.- Adrenarche.- Cardiovascular Disease and Inflammation.- Surgery and Laser Diathermy.- Late Pregnancy Complications in Polycystic Ovary Syndrome.- Glucose Intolerance.- Hormonal and Biochemical Evaluation of Polycystic Ovary Syndrome.- Endometrial Carcinoma in Polycystic Ovary Syndrome.- Statins, Oxidative Stress, and Polycystic Ovary Syndrome.- Glucose Intolerance in Polycystic Ovary Syndrome.- Polycystic Ovary Syndrome.- Anovulation in Polycystic Ovary Syndrome.- Nonalcoholic Fatty Liver Disease in Polycystic Ovary Syndrome.- “Secondary” Polycystic Ovary Syndrome.- Long-Term Sequelae of Polycystic Ovary Syndrome.- The Insulin Resistance of Polycystic Ovary Syndrome.- Therapeutic Aspects of Polycystic Ovary Syndrome in Adolescence.- Lifestyle Intervention in Polycystic Ovarian Syndrome.- Involvement of the Endocannabinoid System in Metabolism and Fertility.- Insulin Resistance.- Clinical Evaluation of Polycystic Ovary Syndrome.- Pharmaceutical Intervention in Metabolic and Cardiovascular risk Factors in Polycystic OvarySyndrome.- Insulin Resistance and Early Pregnancy Loss in Polycystic Ovary Syndrome.